12 citations
,
April 1995 in “Journal of Medicinal Chemistry”
The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.
Finasteride and dutasteride are discussed for hair loss, with concerns about their effects on neurosteroids and potential side effects like depression. Alternatives like topical estrogen and lifestyle changes are considered, with varying opinions on mental health and hair regrowth.
GHK-Cu is a potent inhibitor of the type15-alphareductase enzyme in hair follicles, which may reduce hair loss without the side effects associated with type 2 5-alphareductaseinhibitors. The user previously experienced side effects with 5-alphareductaseinhibitors and is considering GHK-Cu as an alternative.
A 15-year-old is concerned about hair loss, possibly at Norwood 2 or 3, and is using shampoos and conditioners recommended by a trichologist. Suggestions include considering topical minoxidil and consulting a doctor about topical anti-DHT treatments like finasteride or RU58841, but avoiding 5-alpha-reductaseinhibitors at this age.
Epristeride is a selective 5alphareductasetype 2 inhibitor that may reduce scalp DHT similarly to finasteride, with potentially fewer side effects. It is suggested that combining epristeride with finasteride or dutasteride could enhance hair loss treatment effectiveness.
Beta-sitosterol may inhibit 5-alphareductasetype 2 enzyme, potentially reducing DHT levels and promoting hair growth, similar to finasteride but possibly with fewer side effects. Its effectiveness and side effects compared to other treatments like saw palmetto and finasteride remain uncertain due to limited research.